WATSON 460 (Glipizide 5 mg)
Pill imprint WATSON 460 has been identified as Glipizide 5 mg.
Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 5 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for WATSON 460 (Glipizide 5 mg)
- 5 mg
- 8.00 mm
- Prescription only
- Drug Class:
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Watson Laboratories, Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
|NDC Code||Manufacturer / Repackager|
|63739-0116||McKesson Packaging Services|
|54569-3841||A S Medication Solutions LLC (repackager)|
|49999-0108||Lake Erie Medical and Surgical Supply (repackager)|
|63874-0316||Altura Pharmaceuticals Inc (repackager)|
|58016-0876||Southwood Pharmaceuticals Inc (repackager)|
|55289-0806||PDRX Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.